Utility Therapeutics (Acquired By Alembic Pharmaceuticals Inc.)

Utility Therapeutics (Acquired By Alembic Pharmaceuticals Inc.) company information, Employees & Contact Information

UTILITY therapeutics Ltd., a biotechnology company focused on the U.S. development and commercialization of two European-approved antibiotics for the treatment of urinary tract infections (UTI, to address the significant threat faced by healthcare systems and patients from multi-drug resistant bacterial infections. The World Health Organisation has stated that antibiotic resistance is one of the biggest threats to global health, food security, and development today. Pivmecillinam is an oral prodrug of mecillinam that is being developed for uncomplicated UTI (uUTI), and it has a unique mechanism of action for infections caused by Gram-negative bacteria, including extended-spectrum beta-lactamases. Mecillinam, an intravenous (IV) formulation, is being developed as a first-line therapy for complicated UTI (cUTI) in the hospital setting.

Company Details

Employees
4
Founded
-
Address
1 Ashley Road, Altrincham,england Wa14 2dt,united Kingdom
Phone
+44 203 930 9665
Email
in****@****ics.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Altrincham, England
Looking for a particular Utility Therapeutics (Acquired By Alembic Pharmaceuticals Inc.) employee's phone or email?

Utility Therapeutics (Acquired By Alembic Pharmaceuticals Inc.) Questions

Top Utility Therapeutics (Acquired By Alembic Pharmaceuticals Inc.) Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant